60 research outputs found

    An epidermal-specific role for arginase1 during cutaneous wound repair

    Get PDF
    YesNon-healing wounds are a major area of unmet clinical need remaining problematic to treat. Improved understanding of pro-healing mechanisms is invaluable. The enzyme arginase1 is involved in pro-healing responses with its role in macrophages best characterized. Arginase1 is also expressed by keratinocytes; however, arginase1 function in these critical wound repair cells is not understood. We characterized arginase1 expression in keratinocytes during normal cutaneous repair and reveal de novo temporal and spatial expression at the epidermal wound edge. Interestingly, epidermal arginase1 expression was decreased in both human and murine delayed healing wounds. We therefore generated a keratinocyte specific arginase1-null mouse model (K14-cre;Arg1fl/fl) to explore arginase function. Wound repair, linked to changes in keratinocyte proliferation, migration and differentiation, was significantly delayed in K14-cre;Arg1fl/fl mice. Similarly, using the arginase inhibitor nor-NOHA, human in vitro and ex vivo models further confirmed this finding, revealing the importance of the downstream polyamine pathway in repair. Indeed, restoring the balance in arginase1 activity via addition of putrescine, proved beneficial in wound closure. In summary, we demonstrate that epidermal arginase1 plays a, to our knowledge, previously unreported intrinsic role in cutaneous healing, highlighting epidermal arginase1 and downstream mediators as potential targets for the therapeutic modulation of wound repair

    Full adoption of the most effective strategies to mitigate methane emissions by ruminants can help meet the 1.5 °C target by 2030 but not 2050

    Get PDF
    To meet the 1.5 °C target, methane (CH) from ruminants must be reduced by 11 to 30% by 2030 and 24 to 47% by 2050 compared to 2010 levels. A meta-analysis identified strategies to decrease product-based (PB; CH per unit meat or milk) and absolute (ABS) enteric CH emissions while maintaining or increasing animal productivity (AP; weight gain or milk yield). Next, the potential of different adoption rates of one PB or one ABS strategy to contribute to the 1.5 °C target was estimated. The database included findings from 430 peer-reviewed studies, which reported 98 mitigation strategies that can be classified into three categories: animal and feed management, diet formulation, and rumen manipulation. A random-effects meta-analysis weighted by inverse variance was carried out. Three PB strategies—namely, increasing feeding level, decreasing grass maturity, and decreasing dietary forage-to-concentrate ratio—decreased CH per unit meat or milk by on average 12% and increased AP by a median of 17%. Five ABS strategies—namely CH inhibitors, tanniferous forages, electron sinks, oils and fats, and oilseeds—decreased daily methane by on average 21%. Globally, only 100% adoption of the most effective PB and ABS strategies can meet the 1.5 °C target by 2030 but not 2050, because mitigation effects are offset by projected increases in CH due to increasing milk and meat demand. Notably, by 2030 and 2050, low- and middle-income countries may not meet their contribution to the 1.5 °C target for this same reason, whereas high-income countries could meet their contributions due to only a minor projected increase in enteric CH emissions.We thank the GLOBAL NETWORK project for generating part of the database. The GLOBAL NETWORK project (https://globalresearchalliance.org/research/livestock/collaborative-activities/global-research-project/; accessed 20 June 2020) was a multinational initiative funded by the Joint Programming Initiative on Food Security, Agriculture, and Climate Change and was coordinated by the Feed and Nutrition Network (https://globalresearchalliance.org/research/livestock/networks/feed-nutrition-network/; accessed 20 June 2020) within the Livestock Research Group of the Global Research Alliance on Agricultural GHG (https://globalresearchalliance.org; accessed 20 June 2020). We thank MitiGate, which was part of the Animal Change project funded by the EU under Grant Agreement FP7-266018 for sharing their database with us (http://mitigate.ibers.aber.ac.uk/, accessed 1 July 2017). Part of C.A., A.N.H., and S.C.M.’s time in the early stages of this project was funded by the Kravis Scientific Research Fund (New York) and a gift from Sue and Steve Mandel to the Environmental Defense Fund. Another part of C.A.’s work on this project was supported by the National Program for Scientific Research and Advanced Studies - PROCIENCIA within the framework of the "Project for the Improvement and Expansion of the Services of the National System of Science, Technology and Technological Innovation" (Contract No. 016-2019) and by the German Federal Ministry for Economic Cooperation and Development (issued through Deutsche Gesellschaft für Internationale Zusammenarbei) through the research “Programme of Climate Smart Livestock” (Programme 2017.0119.2). Part of A.N.H.’s work was funded by the US Department of Agriculture (Washington, DC) National Institute of Food and Agriculture Federal Appropriations under Project PEN 04539 and Accession no. 1000803. E.K. was supported by the Sesnon Endowed Chair Fund of the University of California, Davis

    Control of Mitochondrial Membrane Permeabilization by Adenine Nucleotide Translocator Interacting with HIV-1 Viral Protein R and Bcl-2

    Get PDF
    Viral protein R (Vpr), an apoptogenic accessory protein encoded by HIV-1, induces mitochondrial membrane permeabilization (MMP) via a specific interaction with the permeability transition pore complex, which comprises the voltage-dependent anion channel (VDAC) in the outer membrane (OM) and the adenine nucleotide translocator (ANT) in the inner membrane. Here, we demonstrate that a synthetic Vpr-derived peptide (Vpr52-96) specifically binds to the intermembrane face of the ANT with an affinity in the nanomolar range. Taking advantage of this specific interaction, we determined the role of ANT in the control of MMP. In planar lipid bilayers, Vpr52-96 and purified ANT cooperatively form large conductance channels. This cooperative channel formation relies on a direct protein–protein interaction since it is abolished by the addition of a peptide corresponding to the Vpr binding site of ANT. When added to isolated mitochondria, Vpr52-96 uncouples the respiratory chain and induces a rapid inner MMP to protons and NADH. This inner MMP precedes outer MMP to cytochrome c. Vpr52-96–induced matrix swelling and inner MMP both are prevented by preincubation of purified mitochondria with recombinant Bcl-2 protein. In contrast to König's polyanion (PA10), a specific inhibitor of the VDAC, Bcl-2 fails to prevent Vpr52-96 from crossing the mitochondrial OM. Rather, Bcl-2 reduces the ANT–Vpr interaction, as determined by affinity purification and plasmon resonance studies. Concomitantly, Bcl-2 suppresses channel formation by the ANT–Vpr complex in synthetic membranes. In conclusion, both Vpr and Bcl-2 modulate MMP through a direct interaction with ANT

    Acute nutritional signals in the control of hind-limb protein turnover in lambs in vivo

    No full text
    Available from British Library Document Supply Centre- DSC:DX94836 / BLDSC - British Library Document Supply CentreSIGLEGBUnited Kingdo
    corecore